In addition, for those individuals with advanced kidney renal clear cell carcinoma (KIRC), CDKN2A deletion is significantly associated with worse overall survival (OS) in patients with tumor-infiltrating T cells after PD-1 blockade [11]. This evidence concerns the gene CDKN2A and neoplasm.